BARBEAU DONALD L has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are KESEL ANDREAS JOHANNES, KOEPF MAIER PETRA and PROCTER & GAMBLE PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Mexico | 1 | |
#8 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Sugars | |
#3 | Special acyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Medical preparations | |
#6 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Barbeau Donald L | 18 |
Publication | Filing date | Title |
---|---|---|
US9198916B1 | Compounds and methods for treating tumors | |
US2012022016A1 | Compounds and methods for selectively targeting tumor-associated mucins | |
US2010240878A1 | Fluorescent saccharide conjugates | |
US2009239820A1 | Compounds and methods for treatment of solid tumors | |
CN101432003A | Noncardiotoxic pharmaceutical compounds | |
CA2576530A1 | Noncardiotoxic pharmaceutical compounds | |
US7119079B2 | Bioadhesive pharmaceutical compositions | |
EP1480649A2 | Stable pharmaceutical compositions |